RTX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RTX, covering 2021-10-05 to 2021-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC [Phase 1, Phase 2]